Last edition
News about "cell therapies"
Acepodia Receives FDA Clearance for ACE723 ADC in Advanced Liver Cancer
Acepodia’s ACE723 is designed to deliver two cytotoxic payloads to GPC3-expressing tumour cells in patients with unresectable or metastatic hepatocellular carcinoma.
Cell Therapies | 07/09/2026 | By News Bureau
TolerogenixX Secures EU Orphan Drug Designation for MIC-Lx in Living-Donor Kidney Transplantation
European Commission grants orphan status to Tolerogenix’s personalized cell therapy following EMA recommendation, strengthening its regulatory pathway alongside recent PRIME designation.
Cell Therapies | 14/07/2026 | By News Bureau | 107
Acepodia Signs Strategic Clinical Partnership with Pfizer for Autoimmune Diseases
Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its cell therapies for oncology and autoimmune diseases.
Cell Therapies | 04/09/2024 | By Aishwarya | 377
Poseida Therapeutics Welcomes Syed Rizvi as New Chief Medical Officer
Poseida Therapeutics, Inc. has appointed Syed Rizvi, MD, as Chief Medical Officer effective April 1, 2024.
<br />
Cell Therapies | 26/03/2024 | By Manvi | 1007
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy